These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12578364)

  • 1. Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach.
    Ewert S; Honegger A; Plückthun A
    Biochemistry; 2003 Feb; 42(6):1517-28. PubMed ID: 12578364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
    Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
    Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
    Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
    Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
    J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach.
    Tanha J; Nguyen TD; Ng A; Ryan S; Ni F; Mackenzie R
    Protein Eng Des Sel; 2006 Nov; 19(11):503-9. PubMed ID: 16971398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
    Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
    Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold.
    Jespers L; Schon O; James LC; Veprintsev D; Winter G
    J Mol Biol; 2004 Apr; 337(4):893-903. PubMed ID: 15033359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical properties of human antibody variable domains.
    Ewert S; Huber T; Honegger A; Plückthun A
    J Mol Biol; 2003 Jan; 325(3):531-53. PubMed ID: 12498801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring local and non-local interactions for protein stability by structural motif engineering.
    Niggemann M; Steipe B
    J Mol Biol; 2000 Feb; 296(1):181-95. PubMed ID: 10656826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains.
    Honegger A; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):687-99. PubMed ID: 11397089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrabody construction and expression III: engineering hyperstable V(H) domains.
    Wirtz P; Steipe B
    Protein Sci; 1999 Nov; 8(11):2245-50. PubMed ID: 10595527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, diversity, and repertoire of VH families in the Mexican axolotl.
    Golub R; Charlemagne J
    J Immunol; 1998 Feb; 160(3):1233-9. PubMed ID: 9570539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition.
    Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B
    J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional mapping of conserved, surface-exposed charges of antibody variable domains.
    Weidenhaupt M; Khalifa MB; Hugo N; Choulier L; Altschuh D; Vernet T
    J Mol Recognit; 2002; 15(2):94-103. PubMed ID: 11954054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
    Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
    Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.